The vulvar cancer drugs market is estimated to be valued at USD 0.640 Bn in 2024 and is expected to reach USD 1.131 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.47% from 2024 to 2031.. https://www.writerscafe.org/kajalpatil/blogs/The-Vulvar-Cancer-Drugs-Market-Set-to-Witness-High-Growth-owing-to-Increasing-Incidence-of-Vulvar-Cancer-Globally/244409/